Psoriasis: one year data from Phase III study evaluating oral Otezla (apremilast) or injectable etanercept versus placebo

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, has announced that results from its ongoing phase III LIBERATE™ trial evaluating Otezla® (apremilast), the...